Randomized, Double-Blind, Placebo-Controlled Crossover Trial of Once Daily Empagliflozin 25 mg for the Treatment of Postprandial Hypoglycemia After Roux-en-Y Gastric Bypass

Antonio Ferreira, Lia Bally, Joanna Gawinecka et al.|Diabetes Technology & Therapeutics|2023

Cited by 13